The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000152.5(GAA):c.658G>T (p.Val220Leu)

CA8814955

255365 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: a1c5bccf-9c05-4db6-ada4-21d24f66c31c
Approved on: 2023-04-04
Published on: 2023-04-05

HGVS expressions

NM_000152.5:c.658G>T
NM_000152.5(GAA):c.658G>T (p.Val220Leu)
NC_000017.11:g.80105860G>T
CM000679.2:g.80105860G>T
NC_000017.10:g.78079659G>T
CM000679.1:g.78079659G>T
NC_000017.9:g.75694254G>T
NG_009822.1:g.9305G>T
ENST00000302262.8:c.658G>T
ENST00000302262.7:c.658G>T
ENST00000390015.7:c.658G>T
ENST00000570803.5:c.658G>T
NM_000152.3:c.658G>T
NM_001079803.1:c.658G>T
NM_001079804.1:c.658G>T
NM_000152.4:c.658G>T
NM_001079803.2:c.658G>T
NM_001079804.2:c.658G>T
NM_001079803.3:c.658G>T
NM_001079804.3:c.658G>T
More

Likely Benign

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Conflicting Evidence"
Met criteria codes 3
PM2_Supporting BS3_Supporting BP4

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Lysosomal Storage Disorders Variant Curation Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000152.5:c.658G>T variant is GAA is a missense variant that is predicted to result in the substitution of valine by leucine at amino acid 220 (p.Val220Leu). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00075 (15/19928 alleles) in the East Asian population which is lower than the ClinGen LSD VCEP threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). When expressed in COS-7 cells, this variant results in normal GAA activity, and the protein is normally synthesized and/or processed (PMID 22644586) (BS3_Supporting). The computational predictor REVEL gives a score of 0.305 which is below the threshold of 0.5, evidence that does not predict a damaging effect on GAA function. No impact on splicing is predicted by SpliceAI (BP4). The variant has been reported in an individual with either suspected Pompe disease or a known carrier, but further details are not available (PMID 22644586). There is a ClinVar entry for this variant (Variation ID: 255365). While there is conflicting evidence, overall, the benign evidence, including functional studies (BS3_Supporting) and in silico data (BP4), outweighs the pathogenic evidence (PM2_Supporting). Therefore, the variant has been classified as likely benign. GAA-specific ACMG/AMP criteria met, based on the specifications of the ClinGen Lysosomal Diseases VCEP (Specifications Version 2.0): PM2_Supporting, BP4, BS3_Supporting (modified classification: likely benign, approved by ClinGen Lysosomal Diseases Variant Curation Expert Panel, April 4, 2023).
Met criteria codes
PM2_Supporting
The highest population minor allele frequency in gnomAD v2.1.1 is 0.00075 (15/19928 alleles) in the East Asian population which is lower than the ClinGen LSD VCEP threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting).
BS3_Supporting
This variant results in 100% GAA activity and the protein is normally synthesized and processed when expressed in COS-7 cells. It was classified as "nonpathogenic" (PMID 22644586), meeting the ClinGen (PS3_Supporting).

BP4
The computational predictor REVEL gives a score of 0.305 which is below the threshold of 0.5, evidence that does not predict a damaging effect on GAA function. No impact on splicing is predicted by SpliceAI (BP4).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.